
Bristol-Myers Squibb Co BMY.N:
BRISTOL MYERS SQUIBB AND PFIZER ANNOUNCE DIRECT-TO-PATIENT ELIQUIS® (APIXABAN) OPTION
BRISTOL-MYERS SQUIBB CO - ELIQUIS 360 SUPPORT PROGRAM NOW OFFERS ELIQUIS TO CASH-PAYING PATIENTS AT MORE THAN 40% DISCOUNT TO CURRENT LIST PRICE
BRISTOL-MYERS SQUIBB CO - ELIQUIS OFFERED AT OVER 40% DISCOUNT TO LIST PRICE
BRISTOL-MYERS SQUIBB CO - ELIGIBLE U.S. PATIENTS CAN PURCHASE ELIQUIS DIRECTLY FROM SEPTEMBER 8